Image analysis (DNA ploidy) and expression of c-erb B-2 and p53 in imprint smears of breast cancer

European Journal of Gynaecological Oncology

Volumn 24, Issue 6, 2003, Pages 531-534

  Malle, D ^a,c   Patakiouta, F ^a   Bousoulegas, A ^a   Karakitsos, P ^b   Destouni, C ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Breast carcinoma; C erb B 2; DNA ploidy; Fine needle aspirates; P53

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; BREAST TUMOR; CONTROLLED STUDY; FEMALE; GENETICS; GENOME IMPRINTING; HUMAN; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; METABOLISM; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PATHOLOGY; PLOIDY; PREDICTION AND FORECASTING; PROGNOSIS; PROTEIN EXPRESSION;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PLOIDIES; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344013046     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Vetrani A., Fulciniti F., Di Benedetto G. et al.: "Fine-needle aspiration biopsies of breast masses. An additional experience with 1153 cases (1985-1988) and a meta-analysis". Cancer, 1992, 69, 736.
2. Spandidos D.A., Anderson M.L.M.: "Oncogenes and oncosuppressor genes: Their involvement in cancer". J. Path., 1989, 157, 1.
3. Bozzetti C., Nizzoli R., Naldi N., Menotti L, Savoldi L., Camisa R. et al.: "Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma". Breast Cancer Res. Treat., 1994, 32, 221.
4. Fernando I.N., Allan S.M., Sandle J., Dean C., Sacks N., Trott P.A.: "Immunocytochemical staining for the c-erb B-2 gene product in breast aspirates: a preliminary report". Cytopathology, 1993, 4, 219.
5. Slamon D.J., Godolphin W., Jones L.A. et al.: "Studies of the HER-2/new proto-oncogene in human breast and ovarian cancer". Science, 1989, 244, 707.
6. Gullick W.J., Love S.B., Wright C. et al.: "c-erb B-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes". Br. J. Cancer, 1991, 63, 434.
7. Ioakim-Liossi A., Markopoulos C., Karakitsos P., Safioleas M., Gogas J., Vaiopoulos G.: "p53 protein expression in benign and malignant breast lesions". Acta Cytologica, 1998, 42 (4), 918.
8. Colecchia M., Frigo B., Zucchi, A., Leopardi O.: "p53 protein expression in fine-needle aspirates of breast cancer: An immunocytochemical assay for identifying high-grade ductal carcinomas". Diagn. Cytopath., 1995, 13 (2), 128.
9. Tiniakos D.G., Robinson K.B., Greenwood H., Cullen P., Cook A. I. M., Horne C. H. W., Angus B.: "c-erb B-2 and p53 expression in breast cancer fine needle aspirates". Cytopath., 1996, 7, 178.
10. Koutselini H., Malliri A., Field J. K., Spandidos D. A.: "p53 expression in cytologic specimens from benign and malignant breast lesions". Anticancer Res., 1991, 11, 1415.
11. Silvestrini R., Benini E., Daidone M.G., Veroni S., Boracchi P., Capelleti V. et al.: "p53 as an independent prognostic marker in lymph node-negative breast cancer patients". J. Natl. Cancer Inst., 1993, 85, 965.
12. Thor A.D., Moore D.H. II, Edgerton S.M., Kawasaki E.S., Reinhsaus E., Lynch H.T. et al.: "Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancer". J. Natl. Cancer Inst., 1992, 84, 845.
13. Jaszez-Gruchala A., Swiatkiewiez I., Lackowska B., Gruchala A., Niezabitowski A.: "Comparative analysis of DNA content estimated by flow and image cytometry in breast tumor samples". Pol. J. Pathol., 2001, 52 (1-2), 15.
14. Klorin G., Keren R.: "Prognostic evaluation of breast cancer in cytologic specimens". Anal. Quant. Cytol. Histol., 2002, 24 (1), 49.
15. Smith F.C., Leal C., Lopes C.: "p53 protein expression and nuclear DNA content in breast intraductal proliferations". J. Pathol., 1995, 233.
16. Ioakim-Liossi A., Pantazopoulos D., Karakitsos P., Athanassiadou P., Aroni K., Chourdakis N. et al.: "DNA ploidy and p53 protein expession in superficial transitional cell carcinoma of the bladder". Cytopathology, 2000, 11 (2), 96.
17. Spiethoff A., Schenck A., Bohrer M.: "Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma". J. Cancer Res. Clin. Oncol., 2000, 126 (12), 707.
18. Rudolph P., Olsson H., Bonatz G., Ratjen V., Bolte H., Baldetorp B. et al.: "Correlation between p53, c-erb B-2 and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications". J. Pathol., 1999, 187 (2), 207.
19. Troncone G., Zeppa P, Fulciniti F. et al.: "C-erb B-2 expression and DNA ploidy status in breast cancer cells obtained by fine needle aspiration (FNA)". Cytopathology, 1993, 4, 195.
20. Wright C., Nicholson S., Angus B. et al.: "Relationship between c-erb B-2 protein product expression and response to endocrine therapy in advanced breast cancer". Br. J. Cancer, 1992, 65, 118.